Accumulation of α-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy (original) (raw)

Abstract

Recently, we have shown that the precursor of the non-Aβ component of Alzheimer’s disease amyloid (NACP), also known as α-synuclein, is a major component of Lewy bodies (LBs) as well as neuronal and glial cytoplasmic inclusions in multiple system atrophy (MSA). To elucidate whether the accumulation of NACP is specific to LB disease and MSA, we further studied 83 autopsied cases with various neurological disorders, using anti-NACP antibodies. In LB disease, NACP immunoreactivity was present in all of the LBs and Lewy neurites in both the central and peripheral nervous systems, the pale bodies in the substantia nigra, and dystrophic neurites in the hippocampal CA2/3 region. Immunoelectron microscopy revealed that the reaction product was localized within filamentous structures and associated granular structures. In MSA, NACP immunoreactivity was found in the intracytoplasmic inclusions of both neuronal and oligodendroglial cells, neuronal intranuclear inclusions, and swollen neuronal processes. No NACP immunoreactivity was found in a variety of other neuronal or glial inclusions in other disorders, including Alzheimer’s disease, Pick’s disease, progressive supranuclear palsy, corticobasal degeneration, motor neuron disease and triplet-repeat diseases. These findings strongly suggest that the accumulation of NACP is a cytopathological feature common to LB disease and MSA.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Brain Disease Research Center, Brain Research Institute, Niigata University, 1 Asahimachi, Niigata 951-8585, Japan e-mail: koichi@bri.niigata-u.ac.jp, Tel.: +81-25-227-0673, Fax: +81-25-227-0817, , , , , , JP
    K. Wakabayashi
  2. Department of Pathology, Brain Research Institute, Niigata University, 1 Asahimachi, Niigata 951-8585, Japan, , , , , , JP
    Shintaro Hayashi, Akiyoshi Kakita, Mitsunori Yamada, Yasuko Toyoshima & Hitoshi Takahashi
  3. Molecular Biology Laboratory, Medicinal Research Laboratories, Taisho Pharmaceutical Co. Ltd., Ohmiya, Saitama 330-0031, Japan, , , , , , JP
    Makoto Yoshimoto

Authors

  1. K. Wakabayashi
    You can also search for this author inPubMed Google Scholar
  2. Shintaro Hayashi
    You can also search for this author inPubMed Google Scholar
  3. Akiyoshi Kakita
    You can also search for this author inPubMed Google Scholar
  4. Mitsunori Yamada
    You can also search for this author inPubMed Google Scholar
  5. Yasuko Toyoshima
    You can also search for this author inPubMed Google Scholar
  6. Makoto Yoshimoto
    You can also search for this author inPubMed Google Scholar
  7. Hitoshi Takahashi
    You can also search for this author inPubMed Google Scholar

Additional information

Received: 15 May 1998 / Revised, accepted: 6 July 1998

Rights and permissions

About this article

Cite this article

Wakabayashi, K., Hayashi, S., Kakita, A. et al. Accumulation of α-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy.Acta Neuropathol 96, 445–452 (1998). https://doi.org/10.1007/s004010050918

Download citation